110 related articles for article (PubMed ID: 25161154)
1. Fluoroquinolones in pediatrics: review of hospital prescription use over 2 years.
Genuini M; Prot-Labarthe S; Bourdon O; Doit C; Aujard Y; Naudin J; Lorrot M
Int J Clin Pharmacol Ther; 2014 Nov; 52(11):940-7. PubMed ID: 25161154
[TBL] [Abstract][Full Text] [Related]
2. Systemic fluoroquinolone prescriptions for hospitalized children in Belgium, results of a multicenter retrospective drug utilization study.
Meesters K; Mauel R; Dhont E; Walle JV; De Bruyne P
BMC Infect Dis; 2018 Feb; 18(1):89. PubMed ID: 29471791
[TBL] [Abstract][Full Text] [Related]
3. Appropriate use of fluoroquinolones in children.
Principi N; Esposito S
Int J Antimicrob Agents; 2015 Apr; 45(4):341-6. PubMed ID: 25726705
[TBL] [Abstract][Full Text] [Related]
4. Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: a population-based cohort study.
Kuo SC; Chen YT; Lee YT; Fan NW; Chen SJ; Li SY; Liu CJ; Chen TL; Chen TJ; Fung CP
Clin Infect Dis; 2014 Jan; 58(2):197-203. PubMed ID: 24170197
[TBL] [Abstract][Full Text] [Related]
5. Oral Fluoroquinolone Prescribing to Children in the United States From 2006 to 2015.
Etminan M; Guo MY; Carleton B
Pediatr Infect Dis J; 2019 Mar; 38(3):268-270. PubMed ID: 29846302
[TBL] [Abstract][Full Text] [Related]
6. Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin.
Yee CL; Duffy C; Gerbino PG; Stryker S; Noel GJ
Pediatr Infect Dis J; 2002 Jun; 21(6):525-9. PubMed ID: 12182376
[TBL] [Abstract][Full Text] [Related]
7. Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.
Cooper MR; Durand CR; Beaulac MT; Steinberg M
Ann Pharmacother; 2011 Sep; 45(9):1094-102. PubMed ID: 21862714
[TBL] [Abstract][Full Text] [Related]
8. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
9. [Prescription of antibiotic drugs for children at the Brazzaville University Hospital Center (Congo)].
Mabiala Babela JR; Ollandzobo Ikobo LC; Mbika Cardorelle A; Moyen G
Med Sante Trop; 2013 May; 23(2):189-92. PubMed ID: 23797761
[TBL] [Abstract][Full Text] [Related]
10. Prospective assessment of fluoroquinolone use in a teaching hospital.
Méan M; Pavese P; Vittoz JP; Foroni L; Decouchon C; Stahl JP; François P
Eur J Clin Microbiol Infect Dis; 2006 Dec; 25(12):757-63. PubMed ID: 17072574
[TBL] [Abstract][Full Text] [Related]
11. [Relevance of fluoroquinolone use in Lorraine: results of the first survey].
Doco-Lecompte T; Demoré B; Burty C; Rondelot G; Scheid P; Zuck P; Simon L; Letranchant L; Robert C; Frentiu E; Petitfrère M; Simplot B; Bevilacqua S; Voltz C; Rabaud C; May T;
Med Mal Infect; 2010 Feb; 40(2):106-11. PubMed ID: 19818570
[TBL] [Abstract][Full Text] [Related]
12. [Prescribing practices of fluoroquinolones in Tunisia].
Hachfi W; Kaabia N; Bougmiza I; Bellazreg F; Hattab Z; Ben Lasfar N; Bahri F; Letaief A
Rev Med Liege; 2011 Apr; 66(4):205-8. PubMed ID: 21638839
[TBL] [Abstract][Full Text] [Related]
13. Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone.
de Lastours V; Chau F; Roy C; Larroque B; Fantin B
J Antimicrob Chemother; 2014 Dec; 69(12):3393-400. PubMed ID: 25063781
[TBL] [Abstract][Full Text] [Related]
14. Urinary tract infections in hospital pediatrics: many previous antibiotherapy and antibiotics resistance, including fluoroquinolones.
Garraffo A; Marguet C; Checoury A; Boyer S; Gardrat A; Houivet E; Caron F
Med Mal Infect; 2014 Feb; 44(2):63-8. PubMed ID: 24512734
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone antibiotics in infants and children.
Schaad UB
Infect Dis Clin North Am; 2005 Sep; 19(3):617-28. PubMed ID: 16102652
[TBL] [Abstract][Full Text] [Related]
16. [Quinolone resistance in Gram negative rods in Iceland and association with antibiotic use].
Jónsdóttir K; Kristinsson KG
Laeknabladid; 2008 Apr; 94(4):279-85. PubMed ID: 18460726
[TBL] [Abstract][Full Text] [Related]
17. [Retrospective survey of fluoroquinolone use in children].
Pariente-Khayat A; Vauzelle-Kervroedan F; d'Athis P; Bréart G; Gendrel D; Aujard Y; Olive G; Pons G
Arch Pediatr; 1998 May; 5(5):484-8. PubMed ID: 9759180
[TBL] [Abstract][Full Text] [Related]
18. Preserving the efficacy of front-line fluoroquinolones through selective use to optimise clinical outcomes.
Lode HM
Int J Antimicrob Agents; 2014 Jun; 43(6):497-507. PubMed ID: 24787481
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia.
Castagnola E; Caviglia I; Pescetto L; Bagnasco F; Haupt R; Bandettini R
Future Microbiol; 2015; 10(3):357-64. PubMed ID: 25812459
[TBL] [Abstract][Full Text] [Related]
20. Analyses of fluoroquinolones and Clostridium difficile-associated diarrhoea in tuberculosis patients.
Chang KC; Leung CC; Yew WW; Lam FM; Ho PL; Chau CH; Cheng VC; Yuen KY
Int J Tuberc Lung Dis; 2009 Mar; 13(3):341-6. PubMed ID: 19275794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
